Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer

Journal of the American College of Surgeons

Volumn 221, Issue 1, 2015, Pages 71-81

  Yao, Katharine ^a,c   Liederbach, Erik ^a   Pesce, Catherine ^a,c   Wang, Chi Hsiung ^b   Winchester, David J ^a,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b EVANSTON HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; AXILLARY LYMPH NODE; AXILLARY NODE DISSECTION; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL RECORD REVIEW; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CLINICAL PRACTICE; EVALUATION STUDY; FACTUAL DATABASE; MIDDLE AGED; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES; SEGMENTAL MASTECTOMY; SENTINEL LYMPH NODE BIOPSY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DATABASES, FACTUAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; LYMPH NODE EXCISION; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY; UNITED STATES;

EID: 84937512811     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2015.02.035     Document Type: Article

References (35)

1. A.E. Giuliano, D.M. Kirgan, J.M. Guenther, and D.L. Morton Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 1994 391 398
2. R.E. Mansel, L. Fallowfield, M. Kissin, and et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the almanac trial J Natl Cancer Inst 98 2006 599 609
3. D.N. Krag, S.J. Anderson, T.B. Julian, and et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase iii trial Lancet Oncol 8 2007 881 888
4. G. Gill Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial Ann Surg Oncol 16 2009 266 275
5. A. Lucci, L.M. McCall, P.D. Beitsch, and et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011 J Clin Oncol 25 2007 3657 3663
6. D.N. Krag, S.J. Anderson, T.B. Julian, and et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol 11 2010 927 933
7. S.B. Edge, J.C. Niland, M.A. Bookman, and et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers J Natl Cancer Inst 95 2003 1514 1521
8. A.Y. Chen, M.T. Halpern, N.M. Schrag, and et al. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005) J Natl Cancer Inst 100 2008 462 474
9. W.J. Gradishar, B.O. Anderson, and S.L. Blair NCCN Clinical Practic Guidelines in Oncology Breast Cancer 2014 Available at: www.nccn.org/professionals/physicians-gls/pdf/breast.pdf
10. A.E. Giuliano, L. McCall, P. Beitsch, and et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 2010 426 432
11. B. Fisher, E. Montague, C. Redmond, and et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial Cancer 39 1977 2827 2839
12. A.E. Giuliano, K.K. Hunt, K.V. Ballman, and et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 2011 569 575
13. V. Galimberti, B.F. Cole, S. Zurrida, and et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial Lancet Oncol 14 2013 297 305
14. D.P. Winchester, A.K. Stewart, C. Bura, and et al. The National Cancer Data Base: a clinical surveillance and quality improvement tool J Surg Oncol 85 2004 1 3
15. K.Y. Bilimoria, A.K. Stewart, D.P. Winchester, and et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the united states Ann Surg Oncol 15 2008 683 690
16. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
17. International Classification Of Diseases For Oncology 3rd ed. 2000 World Health Organization Geneva
18. American College of Surgeons Commision on Cancer Accreditation Categories. Available at: https://www.facs.org/quality-programs/cancer/accredited/about/categories. Accessed April 25, 2014.
19. US Census Statistical groupings of states and counties. Available at: http://www.census.gov/geo/reference/pdfs/GARM/Ch6GARM.pdf. Accessed April 25, 2014.
20. A.E. Giuliano, R.C. Jones, M. Brennan, and et al. Sentinel lymphadenectomy in breast cancer J Clin Oncol 15 1997 2345 2350
21. A.E. Giuliano, P.S. Dale, R.R. Turner, and et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy Ann Surg 222 1995 394 399
22. D. Krag, D. Weaver, T. Ashikaga, and et al. The sentinel node in breast cancer - a multicenter validation study N Engl J Med 339 1998 941 946
23. A.M. Naik, J. Fey, M. Gemignani, and et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures Ann Surg 240 2004 462 468
24. S. Zakaria, A.C. Degnim, C.G. Kleer, and et al. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol 96 2007 554 559
25. J.F. Boileau, A. Easson, J.M. Escallon, and et al. Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed Ann Surg Oncol 15 2008 1710 1716
26. K.Y. Bilimoria, D.J. Bentrem, N.M. Hansen, and et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol 27 2009 2946 2953
27. A.E. Giuliano, M. Morrow, S. Duggal, and et al. Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? Clin Exp Metastasis 29 2012 687 692
28. U. Guth, M.E. Myrick, C.T. Viehl, and et al. The post ACOSOG Z0011 era: does our new understanding of breast cancer really change clinical practice? Eur J Surg Oncol 38 2012 645 650
29. A. Gangi, J. Mirocha, T. Leong, and et al. Triple-negative breast cancer is not associated with increased likelihood of nodal metastases Ann Surg Oncol 21 2014 4098 4103
30. A. Chung, A. Gangi, J. Mirocha, and et al. Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery Ann Surg Oncol 22 2015 1128 1132
31. J.M. Guenther, N.M. Hansen, L.A. DiFronzo, and et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes Arch Surg 138 2003 52 56
32. R.F. Hwang, A.M. Gonzalez-Angulo, M. Yi, and et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection Cancer 110 2007 723 730
33. L. Spiguel, K. Yao, D.J. Winchester, and et al. Sentinel node biopsy alone for node-positive breast cancer: 12-year experience at a single institution J Am Coll Surg 213 2011 122 128
34. Y. Fu, D. Chung, M.A. Cao, and et al. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer? Ann Surg Oncol 21 2014 4109 4123
35. J.C. Boughey A011202: A randomized phase III trial evaluating the role of axillary lymph node dissection in breast cancer patients (cT1-3 N1) who have positive sentinel lymph node disease after neoadjuvant chemotherapy 2014 Available at: www.allianceforclinicaltrialsinoncology.org